A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination-Reference-Cited by-同舟云学术

A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination

Published:2014-06-19 Issue:8 Volume:10 Page:2395-2407
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Reisinger Keith S,Holmes Sandra J,Pedotti Paola,Arora Ashwani Kumar,Lattanzi Maria

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.29393

Reference33 articles.

1. Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly

2. Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States

3. The annual impact of seasonal influenza in the US: Measuring disease burden and costs

4. Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

5. Strategies for mitigating an influenza pandemic

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study;Vaccines;2024-09-10

2. A quadrivalent recombinant influenza Hemagglutinin vaccine induced strong protective immune responses in animal models;Vaccine;2024-09

3. The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods;Vaccines;2024-07-21

4. Immune Potentiation of PLGA Controlled-Release Vaccines for Improved Immunological Outcomes;ACS Omega;2024-02-28

5. The CombE-IDMS Assay as an Alternate Potency Method for Adjuvanted Quadrivalent Influenza Vaccines;Analytical Chemistry;2023-08-16